Ironwood Pharmaceuticals
IRWD
IRWD
149 hedge funds and large institutions have $2.48B invested in Ironwood Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 63 increasing their positions, 39 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
11% less funds holding
Funds holding: 167 → 149 (-18)
11% less capital invested
Capital invested by funds: $2.78B → $2.48B (-$305M)
54% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 28
Holders
149
Holding in Top 10
3
Calls
$12.9M
Puts
$10.4M
Top Buyers
| 1 | +$44.5M | |
| 2 | +$44.3M | |
| 3 | +$26.9M | |
| 4 |
BM
Bridger Management
New York
|
+$22.2M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$15.3M |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$11.9M | |
| 3 | -$9.77M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.28M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$6.01M |